Cargando…

Crystal structure of a covalently linked Aurora-A–MYCN complex

Formation of the Aurora-A–MYCN complex increases levels of the oncogenic transcription factor MYCN in neuroblastoma cells by abrogating its degradation through the ubiquitin proteasome system. While some small-molecule inhibitors of Aurora-A were shown to destabilize MYCN, clinical trials have not b...

Descripción completa

Detalles Bibliográficos
Autores principales:	Diebold, Mathias, Schönemann, Lars, Eilers, Martin, Sotriffer, Christoph, Schindelin, Hermann
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Union of Crystallography 2023
Materias:	Research Papers
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9815099/ https://www.ncbi.nlm.nih.gov/pubmed/36601802 http://dx.doi.org/10.1107/S2059798322011433

Ejemplares similares

PROTAC-mediated degradation reveals a non-catalytic function of AURORA-A kinase
por: Adhikari, Bikash, et al.
Publicado: (2020)

Aurora B kinase is a potent and selective target in MYCN-driven neuroblastoma
por: Bogen, Dominik, et al.
Publicado: (2015)

RanBP9 controls the oligomeric state of CTLH complex assemblies
por: van gen Hassend, Pia Maria, et al.
Publicado: (2023)

Crystal Structure of Human Aurora B in Complex with INCENP and VX-680
por: Elkins, Jonathan M., et al.
Publicado: (2012)

BET and Aurora Kinase A inhibitors synergize against MYCN-positive human glioblastoma cells
por: Čančer, Matko, et al.
Publicado: (2019)

Covalent Aurora A regulation by the metabolic integrator coenzyme A
por: Tsuchiya, Yugo, et al.
Publicado: (2019)

The synergy of BET inhibitors with aurora A kinase inhibitors in MYCN-amplified neuroblastoma is heightened with functional TP53
por: Yi, Joanna S., et al.
Publicado: (2021)

Fragment screening using biolayer interferometry reveals ligands targeting the SHP-motif binding site of the AAA+ ATPase p97
por: Bothe, Sebastian, et al.
Publicado: (2022)

Crystal structures of Mycobacterium tuberculosis GlgE and complexes with non-covalent inhibitors
por: Lindenberger, Jared J., et al.
Publicado: (2015)

An ALYREF-MYCN coactivator complex drives neuroblastoma tumorigenesis through effects on USP3 and MYCN stability
por: Nagy, Zsuzsanna, et al.
Publicado: (2021)

Crystal structure of trioxacarcin A covalently bound to DNA
por: Pfoh, Roland, et al.
Publicado: (2008)

The missing link: covalent linkages in structural models
por: Nicholls, Robert A., et al.
Publicado: (2021)

MYCN and the epigenome
por: He, Stanley, et al.
Publicado: (2013)

Structure of Heteropentameric GABA(A) Receptors and Receptor-Anchoring Properties of Gephyrin
por: Kasaragod, Vikram Babu, et al.
Publicado: (2019)

Structure–Function Relationships of Glycine and GABA(A) Receptors and Their Interplay With the Scaffolding Protein Gephyrin
por: Kasaragod, Vikram B., et al.
Publicado: (2018)

Computational completion of the Aurora interaction region of N-Myc in the Aurora a kinase complex
por: Altiner, Pinar, et al.
Publicado: (2023)

Applications of Ruthenium Complexes Covalently Linked to Nucleic Acid Derivatives
por: Flamme, Marie, et al.
Publicado: (2018)

Reticular design and crystal structure determination of covalent organic frameworks
por: Nguyen, Ha L.
Publicado: (2021)

MYCN is amplified during S phase, and c-myb is involved in controlling MYCN expression and amplification in MYCN-amplified neuroblastoma cell lines
por: Aygun, Nevim, et al.
Publicado: (2019)

Mechanistic investigations into the cyclization and crystallization of benzobisoxazole-linked two-dimensional covalent organic frameworks
por: Pyles, David A., et al.
Publicado: (2018)

Implementation of the plasma MYCN/NAGK ratio to detect MYCN amplification in patients with neuroblastoma
por: Su, Yan, et al.
Publicado: (2020)

MYCN upregulates the transsulfuration pathway to suppress the ferroptotic vulnerability in MYCN-amplified neuroblastoma
por: Floros, Konstantinos V., et al.
Publicado: (2022)

MYCN acts as a direct co-regulator of p53 in MYCN amplified neuroblastoma
por: Agarwal, Saurabh, et al.
Publicado: (2018)

Therapeutic potential of targeting MYCN: A case series report of neuroblastoma with MYCN amplification
por: Huang, Can, et al.
Publicado: (2020)

A MYCN-independent mechanism mediating secretome reprogramming and metastasis in MYCN-amplified neuroblastoma
por: Zhang, Hai-Feng, et al.
Publicado: (2023)

Correlation Between MYCN Gene Status and MYCN Protein Expression in Neuroblastoma: A Pilot Study To Propose the Use of MYCN Immunohistochemistry in Limited-Resource Areas
por: Santiago, Teresa, et al.
Publicado: (2019)

Crystal Structure of SARS-CoV-2 Main Protease in Complex with the Non-Covalent Inhibitor ML188
por: Lockbaum, Gordon J., et al.
Publicado: (2021)

Crystal structure of human CRM1, covalently modified by 2-mercaptoethanol on Cys528, in complex with RanGTP
por: Shaikhqasem, Alaa, et al.
Publicado: (2021)

Amine-Linked Covalent Organic Frameworks as a Platform for Postsynthetic Structure Interconversion and Pore-Wall Modification
por: Grunenberg, Lars, et al.
Publicado: (2021)

Inhibition of mTOR-kinase destabilizes MYCN and is a potential therapy for MYCN-dependent tumors
por: Vaughan, Lynsey, et al.
Publicado: (2016)

Correction: MYCN acts as a direct co-regulator of p53 in MYCN amplified neuroblastoma
por: Agarwal, Saurabh, et al.
Publicado: (2018)

Bulk modulus for polar covalent crystals
por: Xu, Bo, et al.
Publicado: (2013)

FOXR2 Stabilizes MYCN Protein and Identifies Non–MYCN-Amplified Neuroblastoma Patients With Unfavorable Outcome
por: Schmitt-Hoffner, Felix, et al.
Publicado: (2021)

The super elongation complex drives transcriptional addiction in MYCN-amplified neuroblastoma
por: Wang, Donghai, et al.
Publicado: (2023)

Specificity Rendering ‘Hot-Spots’ for Aurora Kinase Inhibitor Design: The Role of Non-Covalent Interactions and Conformational Transitions
por: Badrinarayan, Preethi, et al.
Publicado: (2014)

AffinDB: a freely accessible database of affinities for protein–ligand complexes from the PDB
por: Block, Peter, et al.
Publicado: (2006)

The MYCN Protein in Health and Disease
por: Ruiz-Pérez, María Victoria, et al.
Publicado: (2017)

MYCN Function in Neuroblastoma Development
por: Otte, Jörg, et al.
Publicado: (2021)

MYCN and Metabolic Reprogramming in Neuroblastoma
por: Bansal, Mohit, et al.
Publicado: (2022)

Metastasis in neuroblastoma: the MYCN question
por: Bhavsar, Swapnil Parashram
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_h1stp3oce7arcn5k976f1sfd6u